Works about INFLAMMATORY bowel diseases
Results: 5000
The role of efferocytosis in inflammatory bowel disease.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1524058
- By:
- Publication type:
- Article
Estimating cancer risk in immune-mediated inflammatory diseases exposed to varying doses of tumour necrosis factor inhibitors.
- Published in:
- Journal of Gastroenterology, 2025, v. 60, n. 3, p. 285, doi. 10.1007/s00535-024-02190-z
- By:
- Publication type:
- Article
The causal impact of genetically predicted inflammatory bowel disease on extraintestinal manifestations: a mendelian randomization study.
- Published in:
- BMC Gastroenterology, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12876-024-03566-4
- By:
- Publication type:
- Article
Mesalazine-Induced Acute Pancreatitis in Inflammatory Bowel Disease Patients: A Systematic Review.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Reducing diagnostic delays of extraintestinal manifestations in inflammatory bowel disease: a comparative study of a multidisciplinary outpatient clinic versus conventional referral specialists.
- Published in:
- Therapeutic Advances in Gastroenterology, 2025, p. 1, doi. 10.1177/17562848251323529
- By:
- Publication type:
- Article
Application of the capture–recapture method to ascertain the completeness of the Saxon pediatric IBD registry in Germany.
- Published in:
- Journal of Public Health: From Theory to Practice (2198-1833), 2023, v. 31, n. 11, p. 1899, doi. 10.1007/s10389-022-01749-5
- By:
- Publication type:
- Article
Differences in inflammatory bowel diseases between East and West: a Chinese perspective.
- Published in:
- Journal of Public Health: From Theory to Practice (2198-1833), 2021, v. 29, n. 1, p. 19, doi. 10.1007/s10389-019-01102-3
- By:
- Publication type:
- Article
Epidemiology and care structures for children and adolescents and young adults up to the 26th year of life with inflammatory bowel diseases (IBD) in Leipzig/Saxony/Germany.
- Published in:
- Journal of Public Health: From Theory to Practice (2198-1833), 2018, v. 26, n. 4, p. 437, doi. 10.1007/s10389-017-0884-2
- By:
- Publication type:
- Article
RNA cytidine acetyltransferase NAT10 maintains T cell pathogenicity in inflammatory bowel disease.
- Published in:
- Cell Discovery, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41421-025-00781-5
- By:
- Publication type:
- Article
Vers de nouveaux objectifs thérapeutiques dans les MICI.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2025, v. 32, p. 27, doi. 10.1684/hpg.2025.2948
- By:
- Publication type:
- Article
Les PRO dans les MICI et leur impact sur la qualité de vie.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2025, v. 32, p. 19, doi. 10.1684/hpg.2025.2947
- By:
- Publication type:
- Article
An abundant ginger compound furanodienone alleviates gut inflammation via the xenobiotic nuclear receptor PXR in mice.
- Published in:
- Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-56624-0
- By:
- Publication type:
- Article
Microbiota-derived metabolites in inflammatory bowel disease.
- Published in:
- Seminars in Immunopathology, 2025, v. 47, n. 1, p. 1, doi. 10.1007/s00281-025-01046-9
- By:
- Publication type:
- Article
Roux-en-Y gastric bypass-associated fecal tyramine promotes colon cancer risk via increased DNA damage, cell proliferation, and inflammation.
- Published in:
- Microbiome, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40168-025-02049-2
- By:
- Publication type:
- Article
Bariatric surgery and relevant comorbidities: a systematic review and meta-analysis.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
Peripheral Blood Lymphocyte Subsets as Biomarkers for the Severity of Inflammatory Bowel Disease Subtypes: A Cross-Sectional Study.
- Published in:
- Journal of Contemporary Medical Sciences, 2024, v. 10, n. 6, p. 411, doi. 10.22317/jcms.v10i6.1635
- By:
- Publication type:
- Article
Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort.
- Published in:
- NPJ Genomic Medicine, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41525-025-00480-w
- By:
- Publication type:
- Article
MC-LR induces and exacerbates Colitis in mice through the JAK1/STAT3 pathway.
- Published in:
- Journal of Toxicology & Environmental Health: Part A, 2025, v. 88, n. 9, p. 373, doi. 10.1080/15287394.2024.2443227
- By:
- Publication type:
- Article
Leaky gut in systemic inflammation: exploring the link between gastrointestinal disorders and age-related diseases.
- Published in:
- GeroScience, 2025, v. 47, n. 1, p. 1, doi. 10.1007/s11357-024-01451-2
- By:
- Publication type:
- Article
Research trends of inflammation in autism spectrum disorders: a bibliometric analysis.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1534660
- By:
- Publication type:
- Article
Neurological complications in children and adolescent with Inflammatory Bowel diseases.
- Published in:
- Zagazig University Medical Journal, 2025, v. 31, p. 346, doi. 10.21608/zumj.2024.280809.3302
- By:
- Publication type:
- Article
In Vitro Inhibition of Endoplasmic Reticulum Stress: A Promising Therapeutic Strategy for Patients with Crohn's Disease.
- Published in:
- Cells (2073-4409), 2025, v. 14, n. 4, p. 270, doi. 10.3390/cells14040270
- By:
- Publication type:
- Article
Dual Therapy in Inflammatory Bowel Disease.
- Published in:
- Biomolecules (2218-273X), 2025, v. 15, n. 2, p. 222, doi. 10.3390/biom15020222
- By:
- Publication type:
- Article
Preclinical Long-Term Stability and Forced Degradation Assessment of EPICERTIN, a Mucosal Healing Biotherapeutic for Inflammatory Bowel Disease.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 259, doi. 10.3390/pharmaceutics17020259
- By:
- Publication type:
- Article
pH-Dependent Drug Delivery Systems for Ulcerative Colitis Treatment.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 226, doi. 10.3390/pharmaceutics17020226
- By:
- Publication type:
- Article
Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel Disease †.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 187, doi. 10.3390/pharmaceutics17020187
- By:
- Publication type:
- Article
Drug Development in Inflammatory Bowel Diseases: What Is Next?
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 190, doi. 10.3390/ph18020190
- By:
- Publication type:
- Article
Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 185, doi. 10.3390/ph18020185
- By:
- Publication type:
- Article
Enhancing Tetrahydrocannabinol's Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 148, doi. 10.3390/ph18020148
- By:
- Publication type:
- Article
Bidirectional Interplay Among Non-Coding RNAs, the Microbiome, and the Host During Development and Diseases.
- Published in:
- Genes, 2025, v. 16, n. 2, p. 208, doi. 10.3390/genes16020208
- By:
- Publication type:
- Article
COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) Study.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 104, doi. 10.3390/vaccines13020104
- By:
- Publication type:
- Article
COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) Study.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 104, doi. 10.3390/vaccines13020104
- By:
- Publication type:
- Article
Spatial and Genetic Diversity of Clinical Isolates of Blastocystis in Italy: A Network Analysis.
- Published in:
- Pathogens, 2025, v. 14, n. 2, p. 139, doi. 10.3390/pathogens14020139
- By:
- Publication type:
- Article
Laboratory Tests in Inflammatory Bowel Disease: An Evidence-Based Approach to Daily Practice.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 491, doi. 10.3390/biomedicines13020491
- By:
- Publication type:
- Article
Oral Microbiota and Inflammatory Bowel Diseases: Detection of Emerging Fungal Pathogens and Herpesvirus.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 480, doi. 10.3390/biomedicines13020480
- By:
- Publication type:
- Article
Immune-Mediated Bidirectional Causality Between Inflammatory Bowel Disease and Chronic Periodontitis: Evidence from Mendelian Randomization and Integrative Bioinformatics Analysis.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 476, doi. 10.3390/biomedicines13020476
- By:
- Publication type:
- Article
High-Throughput Whole-Exome Sequencing and Large-Scale Computational Analysis to Identify the Genetic Biomarkers to Predict the Vedolizumab Response Status in Inflammatory Bowel Disease Patients from Saudi Arabia.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 459, doi. 10.3390/biomedicines13020459
- By:
- Publication type:
- Article
Immunohistochemistry Analysis in Inflammatory Bowel Disease—Should We Bring to Light Interleukin-10?
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 406, doi. 10.3390/biomedicines13020406
- By:
- Publication type:
- Article
Beyond the "Master" Role in Allergy: Insights into Intestinal Mast Cell Plasticity and Gastrointestinal Diseases.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 320, doi. 10.3390/biomedicines13020320
- By:
- Publication type:
- Article
Novel Insights into the Pathogenesis of Inflammatory Bowel Diseases.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 305, doi. 10.3390/biomedicines13020305
- By:
- Publication type:
- Article
Investigating the Alleviating Effect of Fucoidan from Apostichopus japonicus on Ulcerative Colitis by Mice Experiments and In Vitro Simulation of Human Fecal Fermentation.
- Published in:
- Foods, 2025, v. 14, n. 4, p. 574, doi. 10.3390/foods14040574
- By:
- Publication type:
- Article
Artificial Intelligence as a Tool in Diagnosing Inflammatory Bowel Disease in Older Adults.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1360, doi. 10.3390/jcm14041360
- By:
- Publication type:
- Article
Temporal Trends in the Use of Biological Agents in Patients with Inflammatory Bowel Disease: Real-World Data from a Tertiary Inflammatory Bowel Disease Greek Center During a 5-Year Period.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1357, doi. 10.3390/jcm14041357
- By:
- Publication type:
- Article
Minimally Invasive Rectal Surgery: Current Status and Future Perspectives in the Era of Digital Surgery.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1234, doi. 10.3390/jcm14041234
- By:
- Publication type:
- Article
Comparative Outcomes of Adalimumab and Infliximab Dose Escalation in Inflammatory Bowel Disease Patients Failing First-Line Biologic Treatment.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1228, doi. 10.3390/jcm14041228
- By:
- Publication type:
- Article
Age as a Predictor of Serum Tumor Necrosis Factor Antagonist Drug and Antidrug Antibody Concentrations in Inflammatory Bowel Disease—A Nationwide Cohort Study.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1057, doi. 10.3390/jcm14041057
- By:
- Publication type:
- Article
Medication Non-Adherence in Inflammatory Bowel Disease: A Systematic Review Identifying Risk Factors and Opportunities for Intervention.
- Published in:
- Pharmacy, 2025, v. 13, n. 1, p. 21, doi. 10.3390/pharmacy13010021
- By:
- Publication type:
- Article
Designing Effective Protocol-Based Pharmacotherapy Management: Assessment of the Development Processes and Outcomes in Inflammatory Bowel Disease Care Prescription Management.
- Published in:
- Pharmacy, 2025, v. 13, n. 1, p. 17, doi. 10.3390/pharmacy13010017
- By:
- Publication type:
- Article
Antioxidant Activity of Bovine Colostrum in the Colon of a Mouse Model of TNBS-Induced Colitis.
- Published in:
- Antioxidants, 2025, v. 14, n. 2, p. 232, doi. 10.3390/antiox14020232
- By:
- Publication type:
- Article
Quality of life of inflammatory bowel diseases patients in france with EQ-5D-5 L: the QALY-MICI study.
- Published in:
- Quality of Life Research, 2025, v. 34, n. 2, p. 405, doi. 10.1007/s11136-024-03821-x
- By:
- Publication type:
- Article